Introduction. The question of whether universal growth charts can be used in multi-ethnic settings is of general interest. The Intergrowth-21st fetal growth and newborn size standards are suggested to represent optimal fetal growth regardless of country origin. Our aim was to examine whether women fulfilling the strict Intergrowth-21st inclusion criteria were healthier, showed less ethnic differences in fetal growth and newborn size, and less adverse perinatal outcomes. Material and methods. Data were drawn from a population-based multi-ethnic cohort of 823 presumably healthy pregnant women in Oslo, Norway. We assessed differences in fetal and neonatal gestational age specific z-scores and compared maternal health parameters, pregnancy and birth complications between pregnancies fulfilling and not fulfilling the Intergrowth21st criteria. Results. Only 21% of pregnancies enrolled in our cohort fulfilled the Intergrowth-21st criteria. Fetal growth deviated substantially from the new standards, in particular for ethnic Europeans. Ethnic differences persisted in pregnancies fulfilling the criteria. In South Asian fetuses, estimated fetal weight was À0.60 SD (95% confidence interval À1.00, À0.20) lower at 24 gestational weeks, and birthweight was À0.62 SD (À0.95, À0.29) lower, compared with ethnic Europeans. Corresponding numbers for Middle-East/North Africans were À0. 13 (À0.62, 0.36) and À0.60 (À1.00, À0.20). Maternal health indicators and birth complications were similar in women fulfilling and not fulfilling the criteria, but the relation depended on ethnic origin. Conclusions. In an urban multi-ethnic Norwegian population, applying an extensive list of criteria to define "healthy" pregnancies excludes the majority of women but does not cancel ethnic differences in fetal growth.
Introduction
Growth charts are important clinical tools, and can be constructed as "growth references" or "growth standards" A growth reference simply describes the growth in a given population. A growth standard, on the other hand, is based on the assumption that fetuses regardless of ethnic background grow similarly under optimal health, environmental and socioeconomic conditions. In 2014, new international fetal growth and newborn size standards suggested for universal use were introduced by the ª 2017 Nordic Federation of Societies of Obstetrics and Gynecology, Acta Obstetricia et Gynecologica Scandinavica 97 (2018) [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] Intergrowth-21st (IG-21) consortium, based on samples of pregnant women from all world regions fulfilling strict inclusion criteria (1, 2) . The IG-21 consortium concluded that the sample represented healthy pregnant women whose nutritional and health needs were met, and hence that the derived growth charts would represent "optimal growth," regardless of ethnic origin (3, 4) . However, two recent studies also aiming at producing fetal growth charts for general use, dispute the IG-21 conclusions (5, 6) .
In multi-ethnic populations, it is essential to know whether one single growth chart can be used for all, as concluded from the IG-21 study, or whether populationspecific reference ranges are more appropriate. To address this question, we used the multi-ethnic population-based STORK-Groruddalen cohort in Oslo, Norway, which has detailed information on a wide range of maternal health parameters, almost all factors included in the IG-21 criteria, and fetal growth and newborn size. The aim of the present study was to test the validity of the IG-21 conclusions. If valid we could expect: (i) applying such criteria would cancel ethnic differences in fetal growth and newborn size, and growth measures would align with the IG-21 sample mean at each time point; (ii) women, across ethnic groups, fulfilling the strict IG-21-criteria would be generally healthier and have fewer adverse perinatal outcomes in comparison with those who do not.
Material and methods

Study sample
In Norway, women with low-risk pregnancies are provided with antenatal care in primary healthcare, free of charge. Most women attend, and rates for adverse perinatal outcomes are generally low, although some ethnic differences exist (7, 8) . Groruddalen, Oslo, has a multi-ethnic population with a diverse socioeconomic status, and the majority of pregnant women (75-85%) attend local Maternal and Child Health Clinics for antenatal care.
Stork Groruddalen is a population-based cohort study of pregnant women recruited during early pregnancy at three local Maternal and Child Health Clinics from May 2008 to May 2010 (9) . Questionnaire data were collected by specially trained midwifes through interviews, supported by a professional interpreter using a translated questionnaires when needed. The women were eligible if they (i) were living in one of the three city districts, (ii) were to give birth at one of the two study hospitals, (iii) were at less than 20 gestational weeks, (iv) were not suffering from diseases necessitating intensive hospital follow-up during pregnancy (including pre-gestational diabetes), (v) could speak Norwegian or one of eight other languages, and (vi) were able to provide informed written consent. The overall participation rate was 74% (ranging between 63 and 82% between ethnic groups) and the study cohort was found representative for women attending the Maternal and Child Health Clinics with respect to ethnicity and age (9) .
Maternal variables
Factors included in the Intergrowth-21st study inclusion criteria. The two IG-21 study samples, Newborn Cross-Sectional Study Prescriptive Subpopulation and the Fetal Growth Longitudinal Study, used the same inclusion criteria, hereafter referred to as the "IG-21 criteria" (Table 1 ). Data were collected at eight study sites, representing all world regions (3). Large study samples were first selected at a population level by recruiting from hospitals serving populations with middle-and high socioeconomic status. Secondly, women were selected at an individual level, based on a number of clinical and nutritional indicators associated with intra-uterine growth restriction (Table 1) (3, 4) . In the Stork Groruddalen cohort we had information on all but four IG-21-criteria ("previous pregnancy affected by preeclampsia/eclampsia, HELLP syndrome or a related pregnancy-associated condition", "positive urine analysis", "clinically significant atypical red cell alloantibodies" and "in an occupation with risk of exposure to chemicals or toxic substances, or very physically demanding activity") (9) . The numbers for these four outcomes were presumably low in our population. Furthermore, occupational exposure/activity in relation to pregnancy is strictly regulated by law in Norway. Hence, the last of these criteria will not apply in this setting. As some IG-21-criteria cut-off values were sitespecific (for example socioeconomic status), we used cutoffs from European sites (3, 10) .
Other maternal variables. Maternal and offspring ethnic origin was defined by the pregnant participant's country of birth. If the participant's mother was born outside
Key Message
Is one growth standard universally applicable, as concluded by the Intergrowth-21st consortium, or are modifications needed to fit various populations or ethnicities? In our multi-ethnic population, strict inclusion criteria, as in Intergrowth-21st, did not uniformly identify women with better health or less adverse perinatal outcomes, and ethnic differences in fetal growth and newborn size persisted.
Europe or North America, the country of origin was defined by the participant's mother's country of birth. Except for Pakistanis (30% second-generation immigrants), very few women of non-European origin were born in Norway. Women were merged into five groups (see footnote to Table 1 ); Europe (n = 379), South Asia (n = 200), East Asia (n = 43), Middle-East/North Africa (n = 172) and Others (n = 29).
Pre-pregnant body mass index (kg/m 2 ) was calculated using self-reported pre-pregnant weight and measured (6) 15 (8) 3 (7) 7 (4) 3 (10) Previous preterm delivery 22 (3) 5 (1) 13 (7) 0 (0) 4 (2) 0 (0) Previous birthweight <2500 g 31 (4) 4 (1) 13 (7) 1 (2) 12 (7) 1 (3) Previous birthweight >4500 g 11 (1)
Medical history/medication h 59 (7) 26 (7) 18 (9) 1 (2) 14 (8) 
112 (14) 30 ( Conditions during the last three months before pregnancy/during pregnancy requiring regular medication or treatment. Isolated pollen-allergy, eczema and hyperemesis were not excluded. The most common conditions were asthma, hypothyroidism, psychiatric disorders (mainly depression), urinary tract infections, hypertension and hormonal medication related to fertilization treatment. i In an occupation with risk of exposure to chemicals or toxic substances, or very physically demanding activity. Such occupational activity during pregnancy is regulated by law in Norway. height (9) . Maternal skin folds were measured twice (triceps, subscapular and suprailiac, with Holtain T/W Caliper 0-48 mm (Holtain Ltd., Crymych, UK), and the mean of the sum was used (11) . Weight gain from prepregnancy to 28 gestational weeks was calculated from measured weight at 28 gestational weeks and the selfreported pre-pregnant weight. Weight gain from gestational 28 gestational weeks to birth was calculated from total weight gain, self-reported at the postnatal visit, and weight at 28 gestational weeks. Parity was categorized as para 0, para 1 or multipara, provided pregnancies lasted at least 22 gestational weeks. Self-reported regular physical activity at inclusion was classified as "regular physical activity" or "no regular physical activity" according to specific criteria (see footnote to Table 2 ) (9).
Fasting venous blood samples were drawn at inclusion and analyzed at certified laboratories (9) . Severe vitamin D deficiency was defined as 25(OH) vitamin D below 25 nmol/L. A standard 75 g oral glucose tolerance test was performed at 28 AE 2 gestational weeks. Gestational diabetes mellitus was diagnosed according to the 1999 World Health Organization criteria (fasting plasma glucose ≥7 mmol/L or 2-h plasma glucose ≥7.8 mmol/L) (9,12).
Pregnancy and birth complications
Data on birth complications and hypertensive disorders in pregnancy (systolic blood pressure >140 mmHg and/or diastolic blood pressure >90 mmHg in early pregnancy, or after 20 gestational weeks, accompanied by new-onset proteinuria) were retrieved from hospital records. A composite birth complication variable was constructed based on the presence of at least one of three events (acute cesarean section, grade 3-4 perineal rupture and Apgar score <7 at 5 min).
Offspring variables
Gestational age was derived from the first day of the woman's last menstrual period, unless this differed more than 14 days from that derived from the routine ultrasound measurements at 17-20 gestational weeks (<7% of women); then the latter was preferred. This differs slightly from the Intergrowth-21st study, where gestational age based on an early ultrasound scan (at 9-13 gestational weeks) was used if the last menstrual period dating differed more than 7 days (2). Preterm birth was defined as birth before 37 +0 gestational weeks.
Fetal ultrasound measurements. We measured head circumference (HC), abdominal circumference (AC), and femur length (FL) (13) and the mean of three measurements was entered in the statistics. Estimated fetal weight (EFW) was calculated using Combs formula: EFW = (0.23718 9 AC 2 9 FL) + (0.03312 9 HC 3 ) (14) . Four experienced clinicians (two obstetricians and two ultrasound midwives, trained at the same hospital) carried out the ultrasound examinations at 24, 32 and 37 gestational weeks according to a study-specific standardized protocol using Voluson Pro (GE-Healthcare) with an AB2-7 scan head. At each session, participants were randomly allocated to the available ultrasound examiner.
Interrater sessions were performed on 24 pregnant women. Two examiners participated in each session, and they performed in total 8-15 examinations each. The intra-class correlation coefficient ranged from 0.95 (FL) to 0.99 (HC, AC and EFW).
Neonatal measurements. Birthweight was routinely measured in grams on calibrated electronic scales immediately after birth. Within 72 h after birth, detailed anthropometric measurements were taken, according to protocol, by specially trained study midwives on the majority (72%) of term neonates (9, 11) . Bi-annual interrater sessions were performed. Crown-heel length (CHlength) and HC were measured to the nearest 0.1 cm (11).
Statistical analyses
Differences between pregnancies fulfilling and not fulfilling all but four IG-21-criteria (hereafter referred to as "pregnancies fulfilling the IG-21 criteria") in total and stratified by ethnic origin (three largest groups only), were tested by t-tests for continuous and chi-square tests for categorical variables.
We derived z-scores for each offspring in the Stork-G cohort, using the z-score calculators available at the Intergrowth-21st homepage, based on the IG-21 Fetal Growth Longitudinal Study sample (HC, AC and FL from 14 to 42 gestational weeks) and from the IG-21 Newborn Cross-Sectional Study sample (weight, HC and CH-length at birth). As standards for EFW during pregnancy and AC at birth were not available from the IG-21 samples, we derived z-scores using a Norwegian reference population and our own study sample to investigate ethnic differences (11, 13) . We then plotted mean zscores against the IG-21 standard mean at each time point, and assessed ethnic differences in mean fetal and neonatal size (mean z-scores) within our cohort, and, restricting the sample to pregnancies lasting more than 37 gestational weeks. SPSS version 22.0 for Windows (SPSS Inc., Chicago, IL, USA) was used. The significance level set to ≤0.050.
Ethical approval
The study protocol was approved by The Regional 
Results
Of 823 women included in the Stork Groruddalen study, only 173 (21%) fulfilled the IG-21 criteria, ranging from 16 to 25% for different ethnic groups (Table 1) . Approximately 20% in all ethnic groups were excluded for reasons related to their last menstrual period date (Table 1) . Other prevalent causes for exclusion were pre-pregnancy smoking, low education, anemia (hemoglobin <11 g/dL), age >35 years and obesity (body mass index >30 kg/m 2 ), but varied by ethnicity. Applying the IG-21 criteria excluded the majority of multiparous Middle East/North African women, whereas this was not the case for the two other ethnic groups (Table 2) .
Does applying the IG-21 criteria cancel ethnic differences in fetal growth and newborn size?
Compared with the IG-21 fetal growth standard, fetuses in the Stork-G cohort had smaller HC, longer FL, and larger AC during pregnancy ( Figure 1a and Table S1 ). At birth, all three measurements were larger than the IG-21 newborn size standard. Restricting the sample to women fulfilling the IG-21-criteria had little impact on the observed deviations. Compared with the IG-21 newborn Table 2 . size standard, European newborns in particular had larger HC, as 36% of ethnic European neonates had HC above the 90th percentile at birth (Table S1 and Figure S1 ). This increased to 47% in women fulfilling the IG-21-criteria (Table S1 and Figure S1 ). Compared with ethnic Europeans, South Asian fetuses were slightly smaller, whereas Middle East/North African fetuses had similar EFW in mid pregnancy (Figure 2 ). However, fetuses in both ethnic minority groups had higher mean FL at this stage of pregnancy ( Figure S1a ) and grew more slowly until birth (Figure 1 ) for all three body measurements ( Figure S1a) . When restricting the sample to women fulfilling the IG-21 criteria, ethnic differences persisted, and even increased for birthweight (Figure 1 ). The ethnic differences in FL at midpregnancy, however, decreased ( Figure S1d ). Do the IG-21-criteria identify pregnant women with better health and fewer adverse perinatal outcomes?
Overall, fewer women fulfilling the IG-21 criteria developed gestational diabetes, compared with those not fulfilling the criteria (Table 2 ). However, this difference was significant only in South Asians, whereas no such trend was observed in Europeans (Tables 3 and 4) . Women fulfilling the criteria were slightly less adipose and had slightly lower serum triglyceride levels in early pregnancy (Table 2 ). However, this difference was not observed in South Asians (Table 3) . Women fulfilling the criteria gained more weight during pregnancy (Tables 2 and 3) .
More ethnic minority women had severe vitamin D deficiency, depressive symptoms and were physically Hypertensive disorder in pregnancy defined as systolic blood pressure >140 mmHg and/or diastolic blood pressure >90 mmHg occurring after 20 gestational weeks, whether or not accompanied by new-onset proteinuria. Numbers presented are from hospital records. Preeclampsia represents women diagnosed with hypertensive disorder from before 34 gestational weeks and/or with important clinical significance, as defined by hospital records. Numbers are probably not fully comparable with the numbers from Intergrowth-21st. f As in the Intergrowth-21st study, numbers are calculated from live born, singleton neonates with birth data. In total there were 13 abortions, eight stillbirths/perinatal deaths, 11 twin-pairs and eight lost to follow-up with no birth data.
g As in the Intergrowth-21st, study numbers are calculated from live born, singleton neonates, born at more than 37 gestational weeks, with birth data (84 and 82% of the total number of births in the respective group). inactive than did ethnic European women (Table 3) , with no significant difference between women fulfilling or not fulfilling the IG-21 criteria. Thus, these ethnic differences persisted. The cesarean section rate was less than half that in the IG-21 study (Table 2 ) (4). Overall, we did not observe significant differences between women fulfilling or not fulfilling the criteria for adverse birth outcomes, such as acute cesarean section, grade 3-4 perineal tear or low Apgar score (Tables 2 and 4) .
Discussion
In this multi-ethnic cohort of presumably healthy pregnant women with expected low-risk pregnancies in Norway, only 21% fulfilled the inclusion criteria used for the IG-21 standards. Fetal growth and newborn size deviated notably from the IG-21 standards, in particular for ethnic Europeans. The fact that those selected according to such strict criteria still maintained ethnic differences in fetal growth and newborn size, challenges the concept that one growth standard fits all. Further, the criteria excluded women differently in various ethnic groups, and those fulfilling the IG-21 criteria were not consistently Results are presented as differences in mean z-score (95% CI). Numbers include only live born, singleton neonates, with valid birth data and at least one ultrasound measurement, born at more than 37 gestational weeks (179 South Asian, 158 Middle East/North African and 346 ethnic European in the total cohort, and 44, 25 and 78, respectively, in pregnancies not fulfilling the IG-21 criteria).
"healthier" or had fewer adverse perinatal outcomes; importantly, the relations varied by ethnicity.
Several studies have demonstrated that some maternal factors, such as anthropometric parameters and current socioeconomic level, affect fetal growth and perinatal outcomes differently according to ethnic groups and settings, possibly due to different stages of sociodemographic transition (15) (16) (17) (18) . Additionally, a range of other maternal factors also influence fetal growth (19) (20) (21) (22) , interacting with each other and with genetic factors, as part of the Moderately intensive activity for 30 min for ≥5 days/week, moderately intensive activity for 2.5 h/week over ≥3 days, vigorous activity for ≥20 min three times per week, or activity of both moderate and vigorous intensity.
adaptive responses made by the fetus to tune its development appropriately to the current conditions (23) . Hence, the nature of these relations, and whether they are similar across different populations, ethnicities and cultures, is scantily understood and therefore possibly not well represented in current inclusion and exclusion criteria. This is in line with our findings that women fulfilling the IG-21 criteria may not necessarily be optimally nourished, for example more than half of South Asian women fulfilling the criteria had severe vitamin D deficiency, whereas this was rare in Europeans. Although the independent effect of vitamin D in the regulation of fetal growth has not been established, there is evidence that maternal vitamin D status may influence obstetric outcomes and fetal tissue development (24) . In contrast, South Asian women fulfilling the IG-21 criteria had a lower and European women a similar prevalence of gestational diabetes to women not fulfilling the criteria. This could indicate that the IG-21 criteria do not identify risk of gestational diabetes similarly in all ethnic groups and hence that the IG-21 growth standards may not reflect "optimal conditions for fetal growth" in all settings.
In our multi-ethnic cohort, we found ethnic differences in fetal and neonatal size irrespective of whether IG-21 criteria were fulfilled. This is in accordance with findings from the two recent studies aiming to develop new fetal Numbers are calculated from live born, singleton neonates, born at more than 37 gestational weeks, with birth data (as in the Intergrowth-21st study). In total there were 13 abortions, eight stillbirths/perinatal deaths, 11 twin-pairs and eight lost to follow-up with no birth data. growth charts; one from USA including women from four ethnic groups (White, Hispanic, Black and Asian) (5), and another from the World Health Organization including 10 countries worldwide (6) . In both studies, differences based on ethnic origin or country were observed from early pregnancy, and were only partially explained by known maternal factors. Customizing growth charts according to maternal factors including ethnicity has long been a promising method of refining the diagnostic application (25) . The recent insights imply that such customization may need a more differential approach than a crude shift in mean and standard deviation to fit individual diagnostic needs (6) . For example, intrauterine growth may follow different trajectories according to population background and size of fetus (5) .
In addition to not being an appropriate standard for expected healthy fetal growth for all, it is a concern that the use of a universal standard in clinical practice could lead to over-diagnosing both large-and small-for-gestational-age fetuses. Ethnic Norwegian newborns are among the largest in the world, with a mean birthweight of almost 3700 g at full term (26) ; for example almost half of ethnic European neonates in our cohort had HC >90 percentile. In other populations, specifically in Asia, where mean birthweight is lower, the opposite would be the case, as demonstrated in a Chinese population (27) . This could have far-reaching consequences for clinical care. Furthermore, if the criteria aiming to identify women that offer "optimal conditions for fetal growth" do not identify women with better perinatal outcomes, one might question whether adopting such standards could do more harm than good, at least for some ethnic groups.
Our study has several strengths, including the population-based design and a multi-ethnic setting. We had information on almost all variables used in the IG-21-study, including maternal data from early pregnancy and offspring growth data from mid-gestation until birth, and a wide range of other variables on maternal clinical parameters and obstetric outcomes. However, our study has some limitations. Applying the criteria on our cohort reduced the number of participants substantially and thereby the statistical power. This limited our possibility to address differences in rare, but perhaps more specific, perinatal outcomes, such as perinatal mortality.
Fetal FL was substantially longer in our cohort, compared with the mean from the IG-21 standard. This is in accordance with recent studies from France and Greece (28, 29) . Furthermore, in our cohort, HC was smaller during pregnancy, but larger at birth, compared with the IG-21. Whether this discrepancy reflects a systematic difference in measurements performed before or after birth between the studies, is unknown. Anthropometric measurements are known to be sensitive to interobserver variation. Although all our biometric data were measured according to a strict protocol, comparable to the one used in the Intergrowth-21st studies, such a bias cannot be ruled out. However, this would not explain the observed ethnic differences within our cohort.
We are just beginning to understand the complexity of fetal growth regulation governed by genetic as well as numerous environmental factors. Our study shows that when using very strict maternal factors to define "healthy" pregnancies, we end up with very few pregnancies. Even under such "optimal" conditions we do not observe less deviation from the growth standards, reduced ethnic differences in fetal growth or newborn size, consistently better maternal health or fewer adverse perinatal outcomes. Hence, we question the validity of using a universal standard.
Supporting information
Additional Supporting Information may be found in the online version of this article: Results are presented as differences in mean z-score (95% CI). Numbers includes only live born, singleton neonates, with valid birth data and at least one ultrasound measurement, born at more than 37 gestational weeks (179 South Asian, 158 Middle East/NorthAfrican and 346 ethnic European in the total cohort, and 44, 25 and 78, respectively, in pregnancies not fulfilling the IG-21 criteria). Table S1 . Mean fetal and neonatal z-scores, and the proportion classified large-or small-for-gestational age, according to the standards developed by the Intergrowth21st consortium, stratified by ethnic origin.
